[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Gastrointestinal Stromal Tumor (GIST) Drug Market Research Report 2017

December 2017 | 114 pages | ID: G27081BEBB0EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Gastrointestinal Stromal Tumor (GIST) Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Gastrointestinal Stromal Tumor (GIST) Drug in these regions, from 2012 to 2022 (forecast), covering
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Global Gastrointestinal Stromal Tumor (GIST) Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
  • Ariad Pharmaceuticals, Inc.
  • Arog Pharmaceuticals, Inc.
  • Array BioPharma Inc.
  • Astex Pharmaceuticals, Inc.
  • Blueprint Medicines Corporation
  • Boston Biomedical, Inc.
  • Calithera Biosciences, Inc.
  • Chipscreen Biosciences Ltd
  • Deciphera Pharmaceuticals, LLC
  • F. Hoffmann-La Roche Ltd.
  • Horizon Pharma Plc
  • Immunicum AB
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Kolltan Pharmaceuticals, Inc.
  • Natco Pharma Limited
  • Nerviano Medical Sciences S.r.l.
  • Novartis AG
  • Omeros Corporation
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Amcasertib
  • Anagrelide hydrochloride CR
  • APG-1351
  • Binimetinib
  • Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
  • Clinic
  • Hospital
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Gastrointestinal Stromal Tumor (GIST) Drug Market Research Report 2017

1 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Gastrointestinal Stromal Tumor (GIST) Drug
1.2 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type (Product Category)
  1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Type (Product Category) in 2016
  1.2.3 Amcasertib
  1.2.4 Anagrelide hydrochloride CR
  1.2.5 APG-1351
  1.2.6 Binimetinib
  1.2.7 Others
1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application
  1.3.1 Gastrointestinal Stromal Tumor (GIST) Drug Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Market by Region (2012-2022)
  1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Gastrointestinal Stromal Tumor (GIST) Drug (2012-2022)
  1.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Status and Outlook (2012-2022)
  1.5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Production and Share by Manufacturers (2012-2017)
2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Share by Manufacturers (2012-2017)
2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Gastrointestinal Stromal Tumor (GIST) Drug Market Competitive Situation and Trends
  2.5.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Concentration Rate
  2.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity and Market Share by Region (2012-2017)
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Production and Market Share by Region (2012-2017)
3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Region (2012-2017)
4.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export, Import (2012-2017)
4.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export, Import (2012-2017)
4.4 China Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export, Import (2012-2017)
4.5 Japan Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export, Import (2012-2017)
4.7 India Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export, Import (2012-2017)

5 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production and Market Share by Type (2012-2017)
5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2012-2017)
5.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Growth by Type (2012-2017)

6 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Market Share by Application (2012-2017)
6.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Ariad Pharmaceuticals, Inc.
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Arog Pharmaceuticals, Inc.
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Array BioPharma Inc.
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Astex Pharmaceuticals, Inc.
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Blueprint Medicines Corporation
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Boston Biomedical, Inc.
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Calithera Biosciences, Inc.
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Chipscreen Biosciences Ltd
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Deciphera Pharmaceuticals, LLC
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 F. Hoffmann-La Roche Ltd.
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 Horizon Pharma Plc
7.12 Immunicum AB
7.13 Jiangsu Hengrui Medicine Co., Ltd.
7.14 Kolltan Pharmaceuticals, Inc.
7.15 Natco Pharma Limited
7.16 Nerviano Medical Sciences S.r.l.
7.17 Novartis AG
7.18 Omeros Corporation

8 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MANUFACTURING COST ANALYSIS

8.1 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Gastrointestinal Stromal Tumor (GIST) Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET FORECAST (2017-2022)

12.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price and Trend Forecast (2017-2022)
12.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Gastrointestinal Stromal Tumor (GIST) Drug
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Amcasertib
Table Major Manufacturers of Amcasertib
Figure Product Picture of Anagrelide hydrochloride CR
Table Major Manufacturers of Anagrelide hydrochloride CR
Figure Product Picture of APG-1351
Table Major Manufacturers of APG-1351
Figure Product Picture of Binimetinib
Table Major Manufacturers of Binimetinib
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption (K Pcs) by Applications (2012-2022)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Applications in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2012-2022)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs) Status and Outlook (2012-2022)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Major Players Product Capacity (K Pcs) (2012-2017)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity (K Pcs) of Key Manufacturers (2012-2017)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity (K Pcs) of Key Manufacturers in 2016
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Major Players Product Production (K Pcs) (2012-2017)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) of Key Manufacturers (2012-2017)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Production Share by Manufacturers (2012-2017)
Figure 2016 Gastrointestinal Stromal Tumor (GIST) Drug Production Share by Manufacturers
Figure 2017 Gastrointestinal Stromal Tumor (GIST) Drug Production Share by Manufacturers
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Major Players Product Revenue (Million USD) (2012-2017)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers
Table 2017 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers
Table Global Market Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
Figure Global Market Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Pcs) of Key Manufacturers in 2016
Table Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Category
Figure Gastrointestinal Stromal Tumor (GIST) Drug Market Share of Top 3 Manufacturers
Figure Gastrointestinal Stromal Tumor (GIST) Drug Market Share of Top 5 Manufacturers
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity (K Pcs) by Region (2012-2017)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity Market Share by Region (2012-2017)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity Market Share by Region (2012-2017)
Figure 2016 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity Market Share by Region
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Region (2012-2017)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) by Region (2012-2017)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Region (2012-2017)
Figure 2016 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Region
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) by Region (2012-2017)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2012-2017)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2012-2017)
Table 2016 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs) and Growth Rate (2012-2017)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table China Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Japan Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table India Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption (K Pcs) Market by Region (2012-2017)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Region (2012-2017)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Region (2012-2017)
Figure 2016 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption (K Pcs) Market Share by Region
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table China Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Japan Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table India Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) by Type (2012-2017)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Production Share by Type (2012-2017)
Figure Production Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2012-2017)
Figure 2016 Production Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) by Type (2012-2017)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2012-2017)
Figure 2016 Revenue Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Type (2012-2017)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Production Growth by Type (2012-2017)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption (K Pcs) by Application (2012-2017)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Application (2012-2017)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Applications (2012-2017)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Application in 2016
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Growth Rate by Application (2012-2017)
Table Ariad Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2012-2017)
Figure Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2012-2017)
Figure Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2012-2017)
Table Arog Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2012-2017)
Figure Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2012-2017)
Figure Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2012-2017)
Table Array BioPharma Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2012-2017)
Figure Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2012-2017)
Figure Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2012-2017)
Table Astex Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2012-2017)
Figure Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2012-2017)
Figure Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2012-2017)
Table Blueprint Medicines Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2012-2017)
Figure Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2012-2017)
Figure Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2012-2017)
Table Boston Biomedical, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2012-2017)
Figure Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2012-2017)
Figure Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2012-2017)
Table Calithera Biosciences, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2012-2017)
Figure Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2012-2017)
Figure Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2012-2017)
Table Chipscreen Biosciences Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2012-2017)
Figure Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2012-2017)
Figure Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2012-2017)
Table Deciphera Pharmaceuticals, LLC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2012-2017)
Figure Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2012-2017)
Figure Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2012-2017)
Table F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal Stromal Tumor (GIST) Drug
Figure Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
Figure Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal Stromal Tumor (GIST) Drug Major Manufacturers in 2016
Table Major Buyers of Gastrointestinal Stromal Tumor (GIST) Drug
Table Distributors/Traders List
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Price (Million USD) and Trend Forecast (2017-2022)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) Forecast by Region (2017-2022)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share Forecast by Region (2017-2022)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption (K Pcs) Forecast by Region (2017-2022)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share Forecast by Region (2017-2022)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) Forecast by Type (2017-2022)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) Forecast by Type (2017-2022)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Price Forecast by Type (2017-2022)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption (K Pcs) Forecast by Application (2017-2022)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption (K Pcs) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source

More Publications

Need Help?

Ask a Question

Market Reports

All Categories